Comparison of structured use of routine laboratory tests or near-patient asessment with clinical judgement in the management of bleeding after cardiac surgery

British Journal of Anaesthesia

Volumn 92, Issue 2, 2004, Pages 178-186

  Avidan, M S ^a,b   Alcock, E L ^b   Da Fonseca, J ^b   Ponte, J ^b   Desai, J B ^b   Despotis, G J ^a   Hunt, B J ^c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Assessment, near patient tests; Complications, bleeding diathesis; Protocol, clinical

Indexed keywords

ADULT; AGED; ALGORITHM; ARTICLE; AUTOANALYZER; BIOASSAY; BLOOD CLOTTING TEST; BLOOD COMPONENT THERAPY; CARDIOPULMONARY BYPASS; CASE CONTROL STUDY; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; ELECTIVE SURGERY; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE DELIVERY; HEART SURGERY; HEMOSTASIS; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEDICAL INSTRUMENTATION; PATIENT CARE; PATIENT INFORMATION; PHYSICIAN; POSTOPERATIVE HEMORRHAGE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; STANDARDIZATION; STATISTICAL ANALYSIS; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY;

EID: 0742272009     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/aeh037     Document Type: Article

References (44)

1. Sanguis Study Group. Use of blood products for elective surgery in 43 European hospitals. The Sanguis Study Group. Transfus Med 1994; 4: 251-68
2. Goodnough LT, Johnston MF, Toy PT. The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group. JAMA 1991; 265: 86-90
3. Stover EP, Siegel LC, Parks R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 1998; 88: 327-33
4. Brown P, Rohwer RG, Dunstan BC, MacAuley C, Gajdusek DC, Drohan WN. The distribution of infectivity in blood components and plasma derivatives in experimental models of transmissible spongiform encephalopathy. Transfusion 1998; 38: 810-6
5. Goodnough LT, Shander A, Brecher ME. Transfusion medicine: looking to the future. Lancet 2003; 361: 161-9
6. Blumberg N, Heal JM. Mortality risks, costs, and decision making in transfusion medicine. Am J Clin Pathol 2000; 114: 934-7
7. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17
8. Dacey LJ, Munoz JJ, Baribeau YR, et al. Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group. Arch Surg 1998; 133: 442-7
9. Moulton MJ, Creswell LL, Mackey ME, Cox JL, Rosenbloom M. Reexploration for bleeding is a risk factor for adverse outcomes after cardiac operations. J Thorac Cardiovasc Surg 1996; 111: 1037-46
10. Hunt BJ, Parratt RN, Segal HC, Sheikh S, Kallis P, Yacoub M. Activation of coagulation and fibrinolysis during cardiothoracic operations. Ann Thorac Surg 1998; 65: 712-8
11. Ferraris VA, Ferraris SP, Singh A, et al. The platelet thrombin receptor and postoperative bleeding. Ann Thorac Surg 1998; 65: 352-8
12. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. [Review]. Blood 1990; 76: 1680-97
13. Despotis GJ, Joist JH, Goodnough LT. Monitoring hemostasis with cardiac surgery: The impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997; 43: 1684-96
14. Consten EC, Henny CP, Eijsman L, Dongelmans DA, van Oers MH. The routine use of fresh frozen plasma in operations with cardiopulmonary bypass is not justified. J Thorac Cordiovasc Surg 1996; 112: 162-7
15. DeLaria GA, Tyner JJ, Hayes CL, Armstrong BW. Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery. Arch Surg 1994; 129: 944-50; discussion 950-1
16. Casati V, Guzzon D, Oppizzi M, et al. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions. J Thorac Cardiovasc Surg 2000; 120: 520-7
17. Despotis GJ, Levine V, Joiner-Maier D, Joist JH. A comparison between continuous infusion versus standard bolus administration of heparin based on monitoring in cardiac surgery. Blood Coagul Fibrinolysis 1997; 8: 419-30
18. Despotis GJ, Gravlee GP, Filos KS, Levy JH. Anticoagulation monitoring during cardiac surgery: a review of current and emerging techniques. Anesthesiology 1999; 91: 1122-51
19. Despotis GJ, Levine V, Saleem R, Spitznagel E, Joist JH. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet 1999; 354: 106-10
20. Nuttall GA, Oliver WC, Santrach PJ, et al. Efficacy of a simple intraoperative transfusion algorithm for nonerythrocyte component utilization after cardiopulmonary bypass. Anesthesiology 2001; 94: 773-81
21. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thrombelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86: 575-8
22. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312-9
23. Guidelines for transfusion for massive blood loss. A publication of the British Society for Haematology. British Committee for Standardization in Haematology Blood Transfusion Task Force. Clin Lab Haematol 1988; 10: 265-73
24. Practice guidelines for blood component therapy: a report by the American Society of Anesthesiologists Task Force on Blood Component Therapy. Anesthesiology 1996; 84: 732-47
25. Cicek S, Demirkilic U, Ozal E, et al. Postoperative use of aprotinin in cardiac operations: an alternative to its prophylactic use. J Thorac Cardiovasc Surg 1996; 112: 1462-7
26. Avidan MS, Da Fonseca J, Parmar K, Alcock E, Ponte J, Hunt BJ. The effects of aprotinin on thromboelastography with three different activators. Anesthesiology 2001; 95: 1169-74
27. Despotis GJ, Joist JH, Hogue CW, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation: a prospective, randomized evaluation in patients undergoing cardiac operations. J Thorac Cardiovasc Surg 1995; 110: 46-54
28. Favaloro EJ. Utility of the PFA-100 for assessing bleeding disorders and monitoring therapy: a review of analytical variables, benefits and limitations. Haemophilia 2001; 7: 170-9
29. Favaloro EJ, Kershaw G, Bukuya M, Hertzberg M, Koutts J. Laboratory diagnosis of von Willebrand disorder (vWD) and monitoring of DDAVP therapy: efficacy of the PFA-100 and vWF: CBA as combined diagnostic strategies. Haemophilia 2001; 7: 180-9
30. Khurana S, Mattson JC, Cohen E, et al. Monitoring platelet GPIIb/IIIa-fibrin interaction with tissue factor-activated thromboelastography. J Lab Clin Med 1997; 130: 401-11
31. Tuman KJ, McCarthy RJ, Djuric M, Rizzo V, Ivankovich AD. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay. J Cardiothorac Vasc Anesth 1994; 8: 144-9
32. NHS Executive. Better blood transfusion. Leeds: NHS Executive, 1998 (HSC 1998/224). http://www.open.gov.uk/doh/coinh.htm
33. McGill N, O'Shaughnessy D, Pickering R, Herbertson M, Gill R. Mechanical methods of reducing blood transfusion in cardiac surgery: randomised controlled trial. BMJ 2002; 324: 1299-303
34. Renton MC, McClelland DB, Sinclair CJ. Use of blood products in cardiac surgery. Perfusion 1997; 12: 157-62
35. Golanski J, Golanski R, Chizynski K, et al. Platelet hyperreactivity after coronary artery bypass grafting: the possible relevance to glycoprotein polymorphisms. A preliminary report. Platelets 2001; 12: 241-7
36. Escudero C, Santos M, Bujan J, et al. Optical aggregometry versus the PFA-100: experimental studies in pigs treated with propofol. Platelets 2001; 12: 133-7
37. Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost 2000; 83: 316-21
38. Despotis GJ, Joist JH, Goodnough LT, Santoro SA, Spitznagel E. Whole blood heparin concentration measurements by automated protamine titration agree with plasma anti-Xa measurements. J Thorac Cardiovasc Surg 1997; 113: 611-3
39. Kasper SM, Giesecke T, Limpers P, Sabatowski R, Mehlhorn U, Diefenbach C. Failure of autologous fresh frozen plasma to reduce blood loss and transfusion requirements in coronary artery bypass surgery. Anesthesiology 2001; 95: 81-6
40. Wajon P, Gibson J, Calcroft R, Hughes C, Thrift B. Intraoperative plateletpheresis and autologous platelet gel do not reduce chest tube drainage or allogeneic blood transfusion after reoperative coronary artery bypass graft. Anesth Analg 2001; 93: 536-42
41. Wallis JP. Editorial I: Transfusion-related acute lung injury (TRALI) - under-diagnosed and under-reported. Br J Anaesth 2003; 90: 573-6
42. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg 2003; 96: 51-7
43. Despotis GJ, Santoro SA, Spitznagel E, et al. On-site prothrombin time, activated partial thromboplastin time, and platelet count. A comparison between whole blood and laboratory assays with coagulation factor analysis in patients presenting for cardiac surgery. Anesthesiology 1994; 80: 338-51
44. Wells AW, Mounter PJ, Chapman CE, Stainsby D, Wallis JP. Where does blood go? Prospective observational study of red cell transfusion in north England. BMJ 2002; 325: 803